Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pittenger

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Molecular Psychiatry|September 11, 2023
Prefrontal cortex astroglia modulate anhedonia-like behaviorS A Codeluppi, M Xu, Y Bansal, et al.
Research Square|July 18, 2023
Prefrontal Cortex Astroglia Modulate Anhedonia-like BehaviorS A Codeluppi, M Xu, Y Bansal, et al.
Molecular Psychiatry|October 19, 2016
Inhibition of STEP<sub>61</sub> ameliorates deficits in mouse and hiPSC-based schizophrenia modelsJ Xu, B J Hartley, P Kurup, et al.
Frontiers in Psychiatry|December 26, 2025
Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysisT H W Ching, B Stahnke, S Shnayder, et al.
Molecular Psychiatry|August 15, 2012
Genome-wide association study of obsessive-compulsive disorderS E Stewart, D Yu, J M Scharf, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Molecular Psychiatry|September 11, 2023
Prefrontal cortex astroglia modulate anhedonia-like behaviorS A Codeluppi, M Xu, Y Bansal, et al.
Research Square|July 18, 2023
Prefrontal Cortex Astroglia Modulate Anhedonia-like BehaviorS A Codeluppi, M Xu, Y Bansal, et al.
Molecular Psychiatry|October 19, 2016
Inhibition of STEP<sub>61</sub> ameliorates deficits in mouse and hiPSC-based schizophrenia modelsJ Xu, B J Hartley, P Kurup, et al.
Frontiers in Psychiatry|December 26, 2025
Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysisT H W Ching, B Stahnke, S Shnayder, et al.
Molecular Psychiatry|August 15, 2012
Genome-wide association study of obsessive-compulsive disorderS E Stewart, D Yu, J M Scharf, et al.
Pageof 3